Results 111 to 120 of about 14,599 (248)

The intriguing possibility of using probiotics in allergen-specific immunotherapy. [PDF]

open access: yesWorld Allergy Organ J, 2023
Furci F   +4 more
europepmc   +1 more source

Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapy

open access: hybrid, 2017
Erika Jensen‐Jarolim   +2 more
openalex   +1 more source

Attenuation of allergen-specific immunotherapy for atopic dermatitis by ectopic colonization of Brevundimonas vesicularis in the intestine. [PDF]

open access: yesCell Rep Med, 2023
Liu X   +12 more
europepmc   +1 more source

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study [PDF]

open access: bronze, 2016
François Spertini   +8 more
openalex   +1 more source

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis

open access: yes
Allergy, EarlyView.
Yue Ma   +10 more
wiley   +1 more source

Tissue Resident Memory Cells: Friend or Foe?

open access: yesImmunology, EarlyView.
Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude   +2 more
wiley   +1 more source

Broad perspectives of allergen specific immunotherapy

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Wayne Robert Thomas
doaj   +1 more source

Mechanisms and biomarkers of successful allergen-specific immunotherapy. [PDF]

open access: yesAsia Pac Allergy, 2022
López JF   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy